Products - Structural heart defects | Topic

Showing 3 products

Date | Title

Heart valve disease in adults
Status:
Awaiting development
Expected publication date:
TBC
Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy [ID6759]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aficamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6668]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC